BioAtla Inc (BCAB)
2.54
+0.29
(+12.89%)
USD |
NASDAQ |
Apr 26, 16:00
2.54
0.00 (0.00%)
After-Hours: 20:00
BioAtla Price to Book Value: 1.729 for April 26, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 26, 2024 | 1.729 |
| April 25, 2024 | 1.531 |
| April 24, 2024 | 1.599 |
| April 23, 2024 | 1.524 |
| April 22, 2024 | 1.484 |
| April 19, 2024 | 1.433 |
| April 18, 2024 | 1.654 |
| April 17, 2024 | 1.722 |
| April 16, 2024 | 1.786 |
| April 15, 2024 | 1.946 |
| April 12, 2024 | 2.130 |
| April 11, 2024 | 2.280 |
| April 10, 2024 | 2.212 |
| April 09, 2024 | 2.430 |
| April 08, 2024 | 2.607 |
| April 05, 2024 | 2.586 |
| April 04, 2024 | 2.668 |
| April 03, 2024 | 2.518 |
| April 02, 2024 | 2.396 |
| April 01, 2024 | 2.307 |
| March 28, 2024 | 2.341 |
| March 27, 2024 | 2.355 |
| March 26, 2024 | 2.048 |
| March 25, 2024 | 1.586 |
| March 22, 2024 | 1.640 |
| Date | Value |
|---|---|
| March 21, 2024 | 1.640 |
| March 20, 2024 | 1.619 |
| March 19, 2024 | 1.674 |
| March 18, 2024 | 1.592 |
| March 15, 2024 | 1.660 |
| March 14, 2024 | 1.622 |
| March 13, 2024 | 1.738 |
| March 12, 2024 | 1.762 |
| March 11, 2024 | 1.939 |
| March 08, 2024 | 1.884 |
| March 07, 2024 | 1.932 |
| March 06, 2024 | 1.932 |
| March 05, 2024 | 1.884 |
| March 04, 2024 | 1.884 |
| March 01, 2024 | 1.939 |
| February 29, 2024 | 1.837 |
| February 28, 2024 | 1.816 |
| February 27, 2024 | 1.932 |
| February 26, 2024 | 1.680 |
| February 23, 2024 | 1.687 |
| February 22, 2024 | 1.606 |
| February 21, 2024 | 1.640 |
| February 20, 2024 | 1.640 |
| February 16, 2024 | 1.538 |
| February 15, 2024 | 1.803 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.4193
Minimum
May 24 2022
11.37
Maximum
Mar 18 2021
2.999
Average
1.663
Median
Sep 26 2022
Price to Book Value Benchmarks
| Marinus Pharmaceuticals Inc | 4.604 |
| Equillium Inc | 2.671 |
| Poseida Therapeutics Inc | 1.982 |
| Biomea Fusion Inc | 2.286 |
| Candel Therapeutics Inc | 14.71 |
Price to Book Value Related Metrics
| Price | 2.54 |
| Earnings Yield | -102.0% |
| Market Cap | 122.17M |